Roger Crystal

This profile gathers the share dealings of Roger Crystal across 2 companies, led by Opiant Pharmaceuticals, Inc. and Definium Therapeutics, Inc. Over a trading history stretching from 16 September 2021 to 11 June 2026, the count stands at 13 filings.

Market trades split into 1 purchase (€1,992) and 6 sales (€243k). On balance, insiders were net sellers of €241k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 5 share grants.

On 15 June 2026 came the latest disclosure, a share grant in Definium Therapeutics, Inc. The last insider purchase was made public on 16 September 2021, 1,858 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.